Sciencast Management’s Cavium, Inc. CAVM Stock Holding History

Sciencast Management’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-6,400	Closed	-$426K	–	505
2017 Q3	$426K	Buy	+6,400	New	+$405K	0.24%	159

Other funds holding CAVM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Sciencast Management's CAVM Position: Q4 2017 in Review

Sciencast Management sold out of Cavium, Inc. (CAVM) in Q4 2017, closing a stake of 6,400 shares — an estimated $426K sold.

Sciencast Management first reported a position in CAVM in Q3 2017 and held it in 1 quarter. The position peaked at $426K in Q3 2017. 264 funds tracked by Wall St. Rank hold CAVM as of Q4 2017.

Sciencast Management reported no remaining Cavium, Inc. position as of Q4 2017 after selling out during the quarter.
Sciencast Management sold 6,400 Cavium, Inc. shares in Q4 2017, an estimated $426K.
Sciencast Management first reported a position in Cavium, Inc. in Q3 2017 and held it in 1 quarter.
Sciencast Management's Cavium, Inc. position peaked at $426K in Q3 2017.
264 funds tracked by Wall St. Rank held Cavium, Inc. as of Q4 2017.

Based on Sciencast Management's 13F filing for Q4 2017, filed 14 Feb 2018.